: iStockAnalyst.com Symbols Feed

Earnings Preview For Nov 3 - 7 - Earnings Preview

Sat, 01 Nov 2008 01:58:00 GMT

Companies that could issue positive surprises include Becton, Dickinson and Company (BDX), SucessFactors (SFSF) and Sunoco (SUN). Penn Virginia Corporation (PVA) could potentially disappoint investors. The Week's Events November has historically been one of the best months for the major markets, according to the[More...]

Analyst Comments: Accenture, Immucor, Luminent Mortgage, ATA, AtriCure, Amicus Therapeutics, Sanderson Farms

Mon, 14 Apr 2008 14:26:56 GMT

This company beat Wall Street estimates for the second quarter by 12.28% on the back of record consulting bookings.[More...]

AtriCure Reports Second Quarter 2009 Financial Results

Tue, 04 Aug 2009 13:52:00 GMT

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced second quarter 2009 revenues of $13.8 million and an operating loss improvement of 43.4 percent to a record $1.0 million.
"We are encouraged by our second quarter results and confident that the decisive actions we took during the fourth quarter of 2008, which were aimed at aligning costs with revenues in order to accelerate profitability, are gaining momentum.
Revenues for the second quarter of 2009 were $13.8 million, a 7.3 percent decrease over second quarter 2008 revenues of $14.9 million and a sequential increase of 0.8 percent as compared to first quarter 2009 revenues.

[More...]

AtriCure Announces August Investor Conference Schedule

Tue, 28 Jul 2009 20:41:00 GMT

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced that it will participate in the following investor conferences during August:[More...]

AtriCure to Announce Second Quarter 2009 Financial Results

Tue, 21 Jul 2009 13:25:00 GMT

AtriCure, Inc. (Nasdaq:ATRC), a medical device company and a leader in cardiac surgical ablation products, will release its financial results for the second quarter ended June 30, 2009 on Tuesday, August 4, 2009 and management will host a conference call at 10:00 a.m. Eastern Time. A live webcast of the conference call will be available from the investor relations page of AtriCure’s corporate web site, www.atricure.com.[More...]

AtriCure Reports First Quarter 2009 Financial Results and Announces New $10 Million Credit Facility

Tue, 05 May 2009 13:55:00 GMT

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today announced first quarter 2009 revenues of $13.7 million.
"We are pleased with our first quarter results and remain confident that, despite a challenging environment, AtriCure is uniquely positioned in high growth markets with the right technologies, capabilities and people.
Revenues for the first quarter of 2009 were $13.7 million, a 1.1% increase over first quarter 2008 revenues of $13.5 million.

[More...]

AtriCure Announces Webcast and Conference Call of First Quarter 2009 Financial Results

Thu, 09 Apr 2009 13:29:00 GMT

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, will release its financial results for the first quarter ended March 31, 2009 on Tuesday, May 5, 2009 and management will host a conference call at 10:00 a.m. Eastern Time. A live webcast of the conference call will be available from the investor relations page of AtriCure’s corporate web site, www.atricure.com.[More...]

AtriCure’s Cryoablation System, Cryo1™, Receives FDA 510(k) Clearance

Fri, 27 Mar 2009 17:17:00 GMT

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in surgical cardiac ablation, today announced that its new innovative disposable cryoablation system, Cryo1, received 510(k) clearance from the Food and Drug Administration, or FDA, for the cryosurgical treatment of cardiac arrhythmias. Additionally, the first patient was successfully treated using the Cryo1 system by Dr. Niv Ad, the Chief of Cardiac Surgery at Inova Fairfax Hospital Department of Cardiovascular and Thoracic Surgery in Falls Church, Virginia. Dr. Ad, an internationally recognized thought leader in the field of cardiac surgery and the surgical treatment of cardiac arrhythmias, successfully used the AtriCure Frigitronics CCS-200 console and the Cryo1 linear disposable ablation probe to perform a minimally invasive, sole therapy cardiac ablation procedure.[More...]

AtriCure Reports Fourth Quarter and Full Year 2008 Financial Results

Thu, 19 Feb 2009 12:30:00 GMT

AtriCure, Inc.:[More...]

AtriCure Announces Web Cast and Conference Call of Fourth Quarter and Full Year 2008 Financial Results

Mon, 09 Feb 2009 20:03:00 GMT

AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation products, will release its financial results for the fourth quarter and year ended December 31, 2008 on Thursday, February 19, 2009.[More...]

Law Offices of Howard G. Smith Announces Update to the Shareholder Lawsuit Against AtriCure, Inc. -- ATRC

Tue, 03 Feb 2009 19:05:00 GMT

Law Offices of Howard G. Smith announces a February 10, 2009, deadline to move to be a lead plaintiff in the securities class action lawsuit filed on behalf of all purchasers of the securities of AtriCure, Inc. between May 10, 2007 and October 31, 2008, inclusive . The shareholder lawsuit is pending in the United States District Court for the Southern District of Ohio.[More...]

Brower Piven Informs Shareholders Who Have Losses in Excess of $100,000 From Investment in AtriCure, Inc. That Only 13 Days Remain Until Deadline to Move for Appointment as Lead Plaintiff in Securities Class Action Lawsuit

Wed, 28 Jan 2009 18:41:00 GMT

BALTIMORE, MD -- -- 01/28/09 -- Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of Ohio on behalf of purchasers of the securities of AtriCure, Inc. during the period between May 10, 2007 and October 31, 2008, inclusive .[More...]